R. Cancio

发表

Classical dengue hemorrhagic fever resulting from two dengue infections spaced 20 years or more apart: Havana, Dengue 3 epidemic, 2001-2002.

M. Guzmán, G. Kourí, E. Martínez, 2005, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Dengue 3 Epidemic, Havana, 2001

M. Guzmán, G. Kourí, J. Pelegrino, 2004, Emerging infectious diseases.

Design, Synthesis, Biological Evaluation, and Molecular Modeling Studies of TIBO‐Like Cyclic Sulfones as Non‐Nucleoside HIV‐1 Reverse Transcriptase Inhibitors

E. Novellino, A. Lavecchia, G. Maga, 2006, ChemMedChem.

Role of the virology diagnosis laboratory in the surveillance of rubella virus Cuba 1988/2000.

M. Guzmán, M. Galindo, D. Rosario, 2004, Vaccine.

Effects of Drug Resistance Mutations L100I and V106A on the Binding of Pyrrolobenzoxazepinone Nonnucleoside Inhibitors to the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Catalytic Complex

G. Maga, S. Gemma, G. Campiani, 2004, Antimicrobial Agents and Chemotherapy.

Discovery of non-nucleoside inhibitors of HIV-1 reverse transcriptase competing with the nucleotide substrate.

M. Radi, S. Zanoli, G. Maga, 2007, Angewandte Chemie.

Unusual Antigenic and Genetic Characteristics of Human Respiratory Syncytial Viruses Isolated in Cuba

J. Melero, I. Martínez, O. Valdés, 1998, Journal of Virology.

Synthesis and biological investigation of S-aryl-S-DABO derivatives as HIV-1 inhibitors.

G. Maga, M. Botta, J. Esté, 2006, Bioorganic & medicinal chemistry letters.

Arylthiopyrrole (AThP) Derivatives as Non‐Nucleoside HIV‐1 Reverse Transcriptase Inhibitors: Synthesis, Structure–Activity Relationships, and Docking Studies (Part 1)

A. Bergamini, E. Novellino, A. Lavecchia, 2006, ChemMedChem.

Detection of respiratory syncytial virus in nasopharyngeal secretions by 24-well plate precentrifugation assay using a monoclonal antibody against F protein.

J. Gavilondo, C. Savón, Á. Goyenechea, 2000, Archives of medical research.

Drug Resistance Mutations in the Nucleotide Binding Pocket of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Differentially Affect the Phosphorolysis-Dependent Primer Unblocking Activity in the Presence of Stavudine and Zidovudine and Its Inhibition by Efavirenz

E. Crespan, G. Maga, U. Hübscher, 2005, Antimicrobial Agents and Chemotherapy.

Parallel solution-phase and microwave-assisted synthesis of new S-DABO derivatives endowed with subnanomolar anti-HIV-1 activity.

E. Crespan, G. Maga, M. Botta, 2005, Journal of medicinal chemistry.

High Potency of Indolyl Aryl Sulfone Nonnucleoside Inhibitors towards Drug-Resistant Human Immunodeficiency Virus Type 1 Reverse Transcriptase Mutants Is Due to Selective Targeting of Different Mechanistic Forms of the Enzyme

E. Crespan, S. Zanoli, G. Maga, 2005, Antimicrobial Agents and Chemotherapy.

HIV-1 reverse transcriptase inhibitors: current issues and future perspectives.

G. Maga, S. Spadari, G. Locatelli, 2004, Current drug metabolism.

Isolation and identification of adenovirus in hospitalized children, under five years, with acute respiratory disease, in Havana, Cuba.

M. Muné, C. Savón, Á. Goyenechea, 2000, Memorias do Instituto Oswaldo Cruz.

Vif is an auxiliary factor of the HIV-1 reverse transcriptase and facilitates abasic site bypass.

G. Maga, S. Spadari, R. Cancio, 2004, The Biochemical journal.

AKAP149 binds to HIV-1 reverse transcriptase and is involved in the reverse transcription.

J. Rain, G. Maga, R. Benarous, 2008, Journal of molecular biology.

Antigenic and genetic characterization of twenty-six strains of human respiratory syncytial virus (subgroup A) isolated during three consecutive outbreaks in Havana city, Cuba.

B. García-Barreno, J. Melero, O. Valdés, 1999, Memorias do Instituto Oswaldo Cruz.

Slow‐, Tight‐Binding HIV‐1 Reverse Transcriptase Non‐Nucleoside Inhibitors Highly Active against Drug‐Resistant Mutants

Gianluca Sbardella, Antonello Mai, Imma Clotet-Codina, 2007, ChemMedChem.

NNRTI-selected mutations at codon 190 of human immunodeficiency virus type 1 reverse transcriptase decrease susceptibility to stavudine and zidovudine.

F. Baldanti, G. Maga, G. Gerna, 2007, Antiviral research.

Gln145Met/Leu Changes in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Confer Resistance to Nucleoside and Nonnucleoside Analogs and Impair Virus Replication

Maurizio Zazzi, Fausto Baldanti, F. Baldanti, 2004, Antimicrobial Agents and Chemotherapy.

N2‐Benzyloxycarbonylguan‐9‐yl Acetic Acid Derivatives as HIV‐1 Reverse Transcriptase Non‐Nucleoside Inhibitors with Decreased Loss of Potency Against Common Drug‐Resistance Mutations.

S. Zanoli, G. Maga, N. Howarth, 2007, ChemMedChem.

AKAP149 binds to HIV-1 reverse transcriptase and is involved in the reverse transcription.

J. Rain, G. Maga, R. Benarous, 2008, Journal of molecular biology.